Cipher Pharmaceuticals Inc
F:PHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cipher Pharmaceuticals Inc
F:PHE
|
CA |
|
DBS Group Holdings Ltd
F:DEV
|
SG |
|
Sofina SA
XBRU:SOF
|
BE |
|
S
|
StoneCo Ltd
XMUN:0Q0
|
KY |
|
Aditya Birla Fashion and Retail Ltd
BSE:535755
|
IN |
|
R
|
Rojukis International PCL
SET:KISS
|
TH |
|
M
|
Molecular Templates Inc
F:NZW1
|
US |
|
H & M Hennes & Mauritz AB
STO:HM B
|
SE |
|
US Energy Corp
NASDAQ:BSIN
|
US |
|
Bosch Ltd
NSE:BOSCHLTD
|
IN |
|
Quest Resource Holding Corp
NASDAQ:QRHC
|
US |
Wall St Price Targets
PHE Price Targets Summary
Cipher Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for PHE is 11 EUR with a low forecast of 9.34 EUR and a high forecast of 12.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHE's stock price target?
Price Target
11
EUR
According to Wall Street analysts, the average 1-year price target for PHE is 11 EUR with a low forecast of 9.34 EUR and a high forecast of 12.56 EUR.
What is the Revenue forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 3 years is 20%.
What is the Operating Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 1 year is 31%.
What is the Pre-Tax Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
27%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 27%.
What is the Net Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
14%
The compound annual growth rate for Net Income over the next 3 years is 14%.
